What should you know about SRS for lung cancer?

In lung cancer discussions, SRS may describe highly precise radiation directed at a small, clearly located target. The target might be in the lung or, in some circumstances, a tumour that has spread to the brain. The team uses imaging to plan beam angles and protect nearby healthy tissue. Suitability depends on tumour number, size and position, breathing movement, lung function, previous treatment and the condition of other organs. SRS is not the right approach for every lung cancer, and it may be combined with surgery, chemotherapy, genomic tumour profiling or other radiotherapy.

Ask how the target was identified and whether a biopsy or other testing is needed. Your team may explain whether the aim is local control, symptom relief or treatment of a limited area after earlier care. Discuss breathing checks, immobilisation, the number of treatment visits and the timing of follow-up scans. Possible effects depend on the treated site and may include tiredness, skin irritation, cough or inflammation in nearby lung tissue. A lung lobectomy can be considered in some situations, while systemic treatment may be more suitable when disease is present in several areas.

Contact your oncology team for a cough that is worsening, new chest discomfort, fever, increasing fatigue or breathlessness that is not settling. Seek urgent medical help for severe difficulty breathing, coughing blood, sudden confusion, a seizure, new weakness or severe chest pain. A hoarse voice can have several causes; report a persistent change so it can be assessed alongside your lung cancer history.

Where is the treatment target? What is the goal of SRS in my plan? How will breathing motion affect planning? What alternatives should I consider? Which symptoms need urgent attention? When will scans and appointments check the response?